Immix Biopharma, Inc. (IMMX)

Last Closing Price: 7.04 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Immix Biopharma, Inc. (IMMX) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-13.93M
Cost of Goods Sold
--
--
$15.95M
$-15.95M
$2.02M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-15.95M
$-15.83M
74.09M
74.09M
$-0.19
$-0.19
Balance Sheet Financials
$338.08M
$2.41M
$7.87M
$345.95M
$10.03M
--
$0.87M
$10.89M
$335.06M
$335.06M
$335.06M
83.81M
Cash Flow Statement Financials
$-33.87M
$-14.16M
$274.41M
$93.93M
$320.32M
$226.39M
$2.84M
--
--
Fundamental Metrics & Ratios
33.72
--
--
--
--
--
--
--
--
--
--
$-34.05M
--
--
--
--
--
--
--
-4.16%
-4.16%
-4.03%
-4.16%
$4.00
$-0.46
$-0.46